On Tuesday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) was -4.69% drop from the session before settling in for the closing price of $1.92. A 52-week range for SLS has been $0.77 – $2.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 45.94% over the past five years. When this article was written, the company’s average yearly earnings per share was at 41.33%. With a float of $103.11 million, this company’s outstanding shares have now reached $105.30 million.
Let’s look at the performance matrix of the company that is accounted for 15 employees.
SELLAS Life Sciences Group Inc (SLS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SELLAS Life Sciences Group Inc stocks. The insider ownership of SELLAS Life Sciences Group Inc is 2.08%, while institutional ownership is 25.57%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.1 earnings per share (EPS) during the time that was better than consensus figure (set at -0.13) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
You can see what SELLAS Life Sciences Group Inc (SLS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
SELLAS Life Sciences Group Inc (NASDAQ: SLS) saw its 5-day average volume 1.84 million, a negative change from its year-to-date volume of 2.53 million. As of the previous 9 days, the stock’s Stochastic %D was 62.89%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 65.13%, which indicates a significant increase from 64.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1280 in the past 14 days, which was lower than the 0.1325 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8181, while its 200-day Moving Average is $1.4131. Nevertheless, the first resistance level for the watch stands at $1.9120 in the near term. At $1.9940, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0375. If the price goes on to break the first support level at $1.7865, it is likely to go to the next support level at $1.7430. The third support level lies at $1.6610 if the price breaches the second support level.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are 105,297K outstanding shares of the company, which has a market capitalization of 192.69 million. As of now, sales total 0 K while income totals -30,880 K. Its latest quarter income was 0 K while its last quarter net income were -6,600 K.
